Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy
Fertility drugs and the risk of breast cancer: a meta-analysis and review
Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109
UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs
The G12 family proteins upregulate matrix metalloproteinase-2 via p53 leading to human breast cell invasion
17β-Estradiol enhances α5 integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells
Synergistic activity of letrozole and sorafenib on breast cancer cells
The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells
New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines
Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissue
Anti-HER2 immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons
Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study
Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation
Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy
The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers
Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors
Are there racial/ethnic disparities among women younger than 40 undergoing mammography?
The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis
XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects
Genetic variants in trinucleotide repeat-containing 9 ( TNRC9 ) are associated with risk of estrogen receptor positive breast cancer in a Chinese population
Association of TGFB1 -509 C>T polymorphism with breast cancer: evidence from a meta-analysis involving 23,579 subjects
Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics
Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer
TMS, a chemically modified herbal derivative of Resveratrol, induces cell death by targeting Bax
Angiosarcoma following MammoSite® partial breast irradiation
Mutation and association analysis of GEN1 in breast cancer susceptibility
Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk
Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis
Comments on: Sluiter MD and van Rensburg EJ, Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation